These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

284 related items for PubMed ID: 10664621

  • 1. Flow cytometric immunophenotypic characterization of pediatric and adult minimally differentiated acute myeloid leukemia (AML-M0).
    Kotylo PK, Seo IS, Smith FO, Heerema NA, Fineberg NS, Miller K, Greene ME, Chou P, Orazi A.
    Am J Clin Pathol; 2000 Feb; 113(2):193-200. PubMed ID: 10664621
    [Abstract] [Full Text] [Related]

  • 2. Diagnostic criteria for minimally differentiated acute myeloid leukemia (AML-M0). Evaluation and a proposal.
    Kaleem Z, White G.
    Am J Clin Pathol; 2001 Jun; 115(6):876-84. PubMed ID: 11392885
    [Abstract] [Full Text] [Related]

  • 3. Myeloid enzymes profile related to the immunophenotypic characteristics of blast cells from patients with acute myeloid leukemia (AML) at diagnosis.
    Klobusicka M, Kusenda J, Babusikova O.
    Neoplasma; 2005 Jun; 52(3):211-8. PubMed ID: 15875082
    [Abstract] [Full Text] [Related]

  • 4. Prognostic value of immunophenotyping in elderly patients with acute myeloid leukemia: a single-institution experience.
    Plesa C, Chelghoum Y, Plesa A, Elhamri M, Tigaud I, Michallet M, Dumontet C, Thomas X.
    Cancer; 2008 Feb 01; 112(3):572-80. PubMed ID: 18085638
    [Abstract] [Full Text] [Related]

  • 5. Characterization of CD13 and CD33 surface antigen-negative acute myeloid leukemia.
    Kraguljac N, Marisavljevic D, Jankovic G, Radosevic N, Pantic M, Donfrid M, Miletic N, Boskovic D, Colovic M.
    Am J Clin Pathol; 2000 Jul 01; 114(1):29-34. PubMed ID: 10884796
    [Abstract] [Full Text] [Related]

  • 6. Transient myeloproliferative disorder and acute myeloid leukemia in Down syndrome. An immunophenotypic analysis.
    Karandikar NJ, Aquino DB, McKenna RW, Kroft SH.
    Am J Clin Pathol; 2001 Aug 01; 116(2):204-10. PubMed ID: 11488066
    [Abstract] [Full Text] [Related]

  • 7. Contrasting antigenic maturation patterns in M0-M2 versus M3 acute myeloid leukemias.
    Lewis RE, Cruse JM, Webb RN, Sanders CM, Beason K.
    Exp Mol Pathol; 2007 Oct 01; 83(2):269-73. PubMed ID: 17603036
    [Abstract] [Full Text] [Related]

  • 8. Characterization of CD34+, CD13+, CD33- cells, a rare subset of immature human hematopoietic cells.
    Gaipa G, Coustan-Smith E, Todisco E, Maglia O, Biondi A, Campana D.
    Haematologica; 2002 Apr 01; 87(4):347-56. PubMed ID: 11940478
    [Abstract] [Full Text] [Related]

  • 9. [Immunologic characteristics and prognosis of acute myeloid leukemia M1].
    Zhao F, Chen Y.
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Aug 01; 15(4):687-91. PubMed ID: 17708783
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. RhG-CSF-mobilized CD34+ peripheral blood progenitors are myeloperoxidase-negative and noncycling irrespective of CD33 or CD13 coexpression.
    Rumi C, Rutella S, Teofili L, Etuk B, Ortu La Barbera E, Micciulli G, Voso MT, Leone G.
    Exp Hematol; 1997 Mar 01; 25(3):246-51. PubMed ID: 9091301
    [Abstract] [Full Text] [Related]

  • 12. Flow cytometric analysis of acute leukemias. Diagnostic utility and critical analysis of data.
    Kaleem Z, Crawford E, Pathan MH, Jasper L, Covinsky MA, Johnson LR, White G.
    Arch Pathol Lab Med; 2003 Jan 01; 127(1):42-8. PubMed ID: 12521365
    [Abstract] [Full Text] [Related]

  • 13. Intracellular markers in acute myeloid leukemia diagnosis.
    Koníková E, Glasová M, Kusenda J, Babusíková O.
    Neoplasma; 1998 Jan 01; 45(5):282-91. PubMed ID: 9921916
    [Abstract] [Full Text] [Related]

  • 14. [Cellular immunophenotypes in 97 adults with acute leukemia].
    Piedras J, López-Karpovitch X, Cárdenas MR.
    Rev Invest Clin; 1997 Jan 01; 49(6):457-64. PubMed ID: 9528305
    [Abstract] [Full Text] [Related]

  • 15. Haematologic and immunophenotypic profile of acute myeloid leukemia: an experience of Tata Memorial Hospital.
    Ghosh S, Shinde SC, Kumaran GS, Sapre RS, Dhond SR, Badrinath Y, Ansari R, Kumar A, Mahadik S, Chougule AB, Nair CN.
    Indian J Cancer; 2003 Jan 01; 40(2):71-6. PubMed ID: 14716122
    [Abstract] [Full Text] [Related]

  • 16. [Flow cytometric analysis of myeloperoxidase negative acute unclassifiable leukemias by monoclonal antibodies. Acute myelogenous and acute megakaryocytic leukemia].
    Imamura N, Kuramoto A, Kawaguchi Y, Tanaka R.
    Rinsho Ketsueki; 1989 Jan 01; 30(1):11-21. PubMed ID: 2541276
    [Abstract] [Full Text] [Related]

  • 17. Discordant expression of myeloid antigens and myeloperoxidase in a case of t(8;21) positive AML expressing CD7.
    Hirai K, Torimoto Y, Moriichi K, Sato K, Ohnishi K, Taya N, Kohgo Y.
    Int J Hematol; 1999 Jul 01; 70(1):30-5. PubMed ID: 10446492
    [Abstract] [Full Text] [Related]

  • 18. The value of dot plot patterns and leukemia-associated phenotypes in AML diagnosis by multiparameter flow cytometry.
    Zelezníková T, Babusíková O.
    Neoplasma; 2005 Jul 01; 52(6):517-22. PubMed ID: 16284699
    [Abstract] [Full Text] [Related]

  • 19. Immunological classification of acute myeloblastic leukemias: relevance to patient outcome.
    Casasnovas RO, Slimane FK, Garand R, Faure GC, Campos L, Deneys V, Bernier M, Falkenrodt A, Lecalvez G, Maynadié M, Béné MC.
    Leukemia; 2003 Mar 01; 17(3):515-27. PubMed ID: 12646939
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.